Baylor College of Medicine and Hess Corp. are giving away 1,000 free Hess Toy Truck STEM (science, technology, engineering, mathematics) kits for teachers to use in their classrooms. The kits include 12 of the 2020 Hess Ambulance and Rescue, a pair of first responder toy trucks that can be used with this year’s corresponding STEM curriculum guide.
The 2020 Hess Toy Truck curriculum guide “STEM to the Rescue” uses the Hess Ambulance and Rescue team as a learning tool to teach students the principles of STEM. This is Baylor’s fifth year collaborating with Hess to develop a free curriculum guide that corresponds with Hess’s featured toy truck. The company’s first toy truck was in 1964 and has been a holiday tradition since.
“This partnership shows how universities and corporations can work together and bring the various strengths that they have to provide learning opportunities for students,” said Dr. Nancy Moreno, chair of the Department of Education, Innovation and Technology and director of the Center for Educational Outreach at Baylor.
Hess is accepting applications from teachers through Dec. 31. The kits will be delivered in February to chosen applicants.
Designed by Baylor’s Center for Educational Outreach, the curriculum guide is divided into seven lessons for elementary and middle school students. The activities apply emergency situations that first responders experience to teach various principles of math and science.
“The point of the activities is to apply STEM skills to real life situations,” said Dr. Gregory Vogt, the primary author of the curriculum guide. “Each of the guide’s activities includes a chart that lists specific STEM skills that are employed in the lesson.”
The activities include using the Hess Ambulance to investigate the angles of inclined planes and learning about force and motion with the Hess Rescue truck. Students also learn how to choose the right gear for the rescue team, measure cargo capacity and handle other emergencies like floods or forest fires.
Vogt adds that the curriculum also introduces students to the medical professions and encourages them to learn about how health sciences universities like Baylor College of Medicine prepare future emergency medical professionals.
Teachers can apply for the free STEM kit on the Hess website. The 2020 Hess Ambulance and Rescue team is available for purchase and the curriculum guide is available for free download on the website: https://hesstoytruck.com/stem.
With Covid-19 hospitalizations spiking again in many parts of the country, public health officials have expressed concerns about a perennial source of strain on the health care system: seasonal flu. As threats of a “twindemic” loom, health care workers have stressed the need for vaccination and other preventive measures to slow the spread of flu.
One insurance company is going further to try to mitigate the effects of flu season: UnitedHealthCare, the country’s largest health insurance company, plans to provide at-risk patients with 200,000 kits that include Tamiflu, the prescription antiviral treatment; a digital thermometer; and a coronavirus P.C.R. diagnostic test. People can take the test at home and then mail it in for laboratory analysis, helping patients and doctors determine the cause of their symptoms, which is particularly important because the coronavirus and flu have similar symptoms but differ in treatment.
“These viruses have proven themselves highly capable of putting strain on our health care system alone,” said Dr. Kelly Moore, an associate director of the Immunization Action Coalition. “Their combined impact is really worrisome.”
In late September, UnitedHealthcare began inviting its Medicare Advantage members to sign up for the kits either online or by phone, starting with a focus on those at highest risk of complications from Covid-19 and the flu based on their age and health status. Since then, 120,000 people have enrolled, and the company has begun shipping the kits. The company has more than 5 million Medicare Advantage members.
The company said supplying people with Tamiflu in advance could help to mitigate the severity of flu infections because the antiviral medication gets less effective with every hour that passes from onset of symptoms and is virtually ineffective after 48 hours. Tamiflu on average shortens the duration of illness by one to two days if taken rapidly, according to Dr. Moore. It can also help prevent illness in someone at high risk of complications who has been exposed to the flu, but is not routinely recommended for preventive use in most populations.
All members signing up for the flu kits had to confirm the state where they live so that the Tamiflu prescription could be dispensed by a physician in their state. They had to attest, either over the phone or through an online form, that they would wait to take the prescription drug or the coronavirus test until after receiving direction from a physician through a telemedicine appointment, though there is no additional system for verifying this process once they receive their kits. Members also had to agree not to give the medication to others.
“We thought, ‘Imagine if you start getting sick and already had a mini pharmacy at home,’” said Dr. Deneen Vojta, executive vice president for research and development at UnitedHealthcare. The goal, she added, is to decrease the number of emergency room visits, hospitalizations and deaths resulting from seasonal flu.
There is no charge for the Tamiflu or the coronavirus test, as long as people receive advice from a doctor via
Primo Nutraceuticals Inc. signs a Memorandum of Understanding for Exclusive Rights to Sell Rapid (Colloidal Gold Method) COVID-19 Test Kits in Canada
COVID-19 Test Kits
COVID-19 Test Kits
VANCOUVER, British Columbia, Oct. 21, 2020 (GLOBE NEWSWIRE) — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF ) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (” PRIMO ” or the “Company”) announces the signing of a Memorandum of Understanding (MOU) with Neo-Nostics ™ (Suzhou) Bioengineering Co. Ltd. Of Su Zhou City, China (“Neo-Nostics”) as the official trade representative for Neo-Nostics ™ with the exclusive rights to apply for licensing and to market and sell the following COVID-19 production Canada: Neo-Nostics ™ 2019-nCoV IgG/IgM Rapid Test Kit (Colloidal Gold Method) (Test Kit).
The Memorandum of Understanding between Primo and Neo-Nostics ™, is effective as of October 13, 2020. Upon successfully receiving product license and approval by Health Canada, Neo-Nostics ™ will grant Primo with “Official Dealer/Distributor Status” in Canada.
The Neo-Nostics ™ 2019-nCoV IgG/IgM Rapid Testing Kit is currently registered with the FDA. Primo will be submitting the application for approval to Health Canada immediately. Neo-Nostics ™ has committed to supporting Primo’s efforts to obtain and maintain all necessary certifications and approvals for the sale and marketing of the Test Kits in Canada by granting access to all necessary documentation and clinical studies concerning the Test Kits.
Follow the link for a video demonstration: http://www.neo-nostics.com/skin/images/mp40.mp4
About the Neo-Nostics ™ Rapid Test Kits
The Neo-Nostics ™ 2019-nCoV Antibody Detection Reagent Kit (Colloidal Gold Method) has the advantage of rapidity, convenience, high accuracy, and can make up for the shortcomings of professional requirements, time consumption and low positive detection rate of PCR nucleic acid detection, and can be used as an important supplementary detection method for the diagnosis of coronal pneumonia.
Through detection and calculation, it is found that the comprehensive accuracy rate of the Neo-Nostics ™ 2019-nCoV IgM Detection Reagent is higher than 95%.
During the worst period of the epidemic in China, the reagent kit was donated to hospitals and the CDC in the most severely infected areas of Hubei for clinical auxiliary diagnosis. At present, the verification reports made by three clinical units prove that the positive detection rate of clinically confirmed cases has reached 92%, which has exceeded the general detection effect. Not only negative or positive results can be detected, but also the early, middle and or recovery period of virus infection can be distinguished by the positive strength of IgM or IgG.
Source: Clinical study report conducted by the Institute of Virology, in the capital city of Hubei, China and The Chinese Academy of Sciences in Beijing, China.
DISCLAIMER: “The Company is not making any express or implied claims that it has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time”.
Clinical Applications of Reagents
This reagent has been used by professionals in China since February 2020 in an area that was the hardest hit and impacted most severely by COVID-19, in the form of clinical auxiliary diagnosis.
The reagent kit was clinically verified by several professionals, hospitals, and universities respectively, and